George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,272.00
Bid: 3,278.00
Ask: 3,280.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.061%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3,272.00
EXPN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Experian agrees to sell Email/CCM business

3 Apr 2017 09:00

RNS Number : 3293B
Experian plc
03 April 2017
 

Experian 

news release

 

 

Experian signs agreement to sell controlling interest in Email/Cross-Channel Marketing in a further step to sharpen strategic focus

 

3 April 2017 - Experian, the global information services company, announces that it has signed a definitive agreement to sell its Email/Cross-Channel Marketing business (CCM) to Vector Capital.

 

The enterprise value of CCM at completion is c. US$400m on a cash and debt free basis. Experian has agreed to divest a 75% interest in CCM to Vector Capital, with Experian retaining the balance. The transaction is subject to customary closing conditions and is expected to complete during the first half of the financial year ending 31 March 2018.

 

Brian Cassin, Chief Executive Officer said:

 

"Two years ago we introduced our new strategy and one of its five key pillars has been to further focus our portfolio. In November 2016, we stated that following a strategic review of Marketing Services we saw fewer synergies between CCM and other parts of Experian. CCM has been a great investment for Experian, having rapidly grown from small acquisitions to become one of the leading global players in the industry. With the actions we've taken over the past two years to further improve the business, it is starting to regain momentum, and under new ownership it is well positioned to continue to make progress.

"Vector Capital is a leading technology investor with a strong track record. The combined expertise of the CCM and Vector Capital operating teams will draw on the strength of both the CCM team and of industry leaders hired by Vector Capital, including Peter McCormick, the co-founder of ExactTarget. This will enable CCM to realise its ambition to serve the biggest brands in the world and fully seize the opportunities ahead. We believe this will lead to significant future benefits for Vector Capital, Experian and the CCM team."

Further information:

CCM provides services which help clients to develop, target and deliver marketing offers to consumers through email and across multiple online channels. It has formed part of Experian's Marketing Services business.

In view of our agreement to sell a controlling stake, CCM will be treated as a discontinued operation in the Group's financial statements for the year ended 31 March 2017. As such CCM's contribution will be excluded from organic revenue growth, Benchmark profit before tax and Benchmark earnings per share (EPS). For the year ended 31 March 2017, CCM is expected to generate EBIT of c. $52m and has a pro forma effect on Benchmark EPS of 3 cents, before taking into account the redeployment of net cash proceeds.

Net proceeds on closing to Experian will be 75% of the enterprise value, and will be after transaction costs and taxes. Experian will retain a 25% equity interest in CCM and a seller note for US$75m. On a pro forma basis net debt to EBITDA is expected to be c.1.9-2.0x at 31 March 2017, compared to the Group's target range of 2-2.5x.

 

 

 

Contact:

Experian

Andrew Simms Head of Investor Relations +44 (0)20 3042 4215

Gerry Tschopp Senior VP, Group Communications +1 714 830 7756

 

Finsbury

Rollo Head +44 (0)20 7251 3801

Jenny Davey

 

Morgan Stanley & Co. LLC served as Experian's exclusive financial advisor in connection with the transaction.

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 17,000 people operating across 37 countries and every day we're investing in new technologies, talented people and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFVDSAIVIID
Date   Source Headline
18th May 202310:20 amRNSDirector/PDMR Shareholding
17th May 20234:00 pmRNSDirector/PDMR Shareholding
17th May 202311:00 amRNSShare repurchases
17th May 20237:00 amRNSFull-year financial report
28th Apr 202310:15 amRNSTotal Voting Rights
12th Apr 20239:30 amRNSAdditional Listing
4th Apr 20239:45 amRNSAdditional Listing
31st Mar 202311:35 amRNSTotal Voting Rights
29th Mar 20239:20 amRNSAdditional Listing
28th Mar 20237:00 amRNSDirectorate Change
22nd Mar 20235:19 pmRNSTransaction in Own Shares
22nd Mar 20239:15 amRNSAdditional Listing
20th Mar 20235:18 pmRNSTransaction in Own Shares
17th Mar 20235:31 pmRNSTransaction in Own Shares
16th Mar 20235:09 pmRNSTransaction in Own Shares
16th Mar 20239:15 amRNSBlock listing Interim Review
15th Mar 20235:14 pmRNSTransaction in Own Shares
15th Mar 20239:15 amRNSAdditional Listing
14th Mar 20235:21 pmRNSTransaction in Own Shares
13th Mar 20235:31 pmRNSTransaction in Own Shares
10th Mar 20236:10 pmRNSTransaction in Own Shares
9th Mar 20235:22 pmRNSTransaction in Own Shares
8th Mar 20235:21 pmRNSTransaction in Own Shares
8th Mar 20239:15 amRNSAdditional Listing
7th Mar 20235:26 pmRNSTransaction in Own Shares
1st Mar 202312:00 pmRNSDirector/PDMR Shareholding
1st Mar 20239:15 amRNSAdditional Listing
28th Feb 202312:20 pmRNSTotal Voting Rights
22nd Feb 202310:00 amRNSAdditional Listing
15th Feb 202310:45 amRNSAdditional Listing
10th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20239:30 amRNSAdditional Listing
1st Feb 20239:15 amRNSAdditional Listing
31st Jan 20232:30 pmRNSDirector Declaration
31st Jan 202310:15 amRNSTotal Voting Rights
25th Jan 20239:15 amRNSAdditional Listing
17th Jan 20237:00 amRNSExperian Q3 FY23 trading update
13th Jan 20235:20 pmRNSFirst interim dividend
9th Jan 20237:00 amRNSDirectorate Change
30th Dec 202210:15 amRNSTotal Voting Rights
16th Dec 202211:30 amRNSElections for first interim dividend
14th Dec 20229:15 amRNSAdditional Listing
7th Dec 20229:00 amRNSAdditional Listing
30th Nov 202211:59 amRNSTotal Voting Rights
16th Nov 20227:00 amRNSHalf-year Report
31st Oct 20229:30 amRNSTotal Voting Rights
14th Oct 20229:51 amRNSShare Repurchase Programme
6th Oct 20227:00 amRNSDirectorate Change
5th Oct 20229:10 amRNSAdditional Listing
30th Sep 202212:06 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.